{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:48Z","timestamp":1786119588286,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/dad.0b013e3181e02f29","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T06:48:00Z","timestamp":1285829280000},"page":"809-814","source":"Crossref","is-referenced-by-count":22,"title":["Diagnostic and Prognostic Role of Galectin 3 Expression in Cutaneous Melanoma"],"prefix":"10.1097","volume":"32","author":[{"given":"Asmaa Gaber","family":"Abdou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawky El","family":"Farargy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza G A","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Nabil","family":"El Shafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Farag","family":"Elnaidany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0046-8177(96)90157-4","article-title":"Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.","volume":"27","author":"Farmer","year":"1996","journal-title":"Hum Pathol"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1073\/pnas.0901185106","article-title":"A multi-marker assay to distinguish malignant melanomas from benign nevi.","volume":"14","author":"Kashani-Sabet","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3346\/jkms.2007.22.4.621","article-title":"Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.","volume":"22","author":"Park","year":"2007","journal-title":"J Korean Med Sci"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11670-004-0022-x","article-title":"Expression of galectin-3 in gastric carcinoma and its significance.","volume":"3","author":"Chun-sheng","year":"2004","journal-title":"Chinese J Cancer Res"},{"key":"R7-11-20210202","first-page":"3117","article-title":"Galectin-3 expression is a potent prognostic marker in colorectal cancer.","volume":"25","author":"Endo","year":"2005","journal-title":"Anticancer Res"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1872-034X.2008.00387.x","article-title":"Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma.","volume":"38","author":"Matsuda","year":"2008","journal-title":"Hepatol Res"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000193223","article-title":"Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.","volume":"120","author":"Kim","year":"2008","journal-title":"Acta Haematol"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.52.7.517","article-title":"Ki-67, oestrogen receptor, and progesterone receptor proteins in the human rete ovarii and in endometriosis.","volume":"52","author":"Khan","year":"1999","journal-title":"J Clin Pathol"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002920050051","article-title":"Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistological diagnosis of occult neoplasms.","volume":"15","author":"Achilles","year":"1994","journal-title":"Pathologe"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.humpath.2007.12.006","article-title":"KBA.62: a useful marker for primary and metastatic melanomas.","volume":"39","author":"Pages","year":"2008","journal-title":"Hum Pathol"},{"issue":"s2","key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2008.01130.x","article-title":"Use of immunohistochemistry in melanocytic lesions.","volume":"35","author":"Prieto","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/40.2.1552165","article-title":"Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes.","volume":"40","author":"Kapur","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00000372-200412000-00002","article-title":"Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.","volume":"26","author":"Kucher","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1034\/j.1600-0560.2001.028008393.x","article-title":"S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi.","volume":"28","author":"Fullen","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00000478-199808000-00007","article-title":"Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1309\/EWK9-LUPR-6BC5-1GXV","article-title":"Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.","volume":"118","author":"Sheffield","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2133.1996.d01-1012.x","article-title":"Expression and ultrastructural localization of HMB-45 antigen.","volume":"135","author":"Kikuchi","year":"1996","journal-title":"Br J Dermatol"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000478-200201000-00010","article-title":"Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.","volume":"26","author":"Xu","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1600-0714.2005.00340.x","article-title":"HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.","volume":"34","author":"Yu","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CMR.0b013e328317f04b","article-title":"Unusual presentation of metastatic amelanotic melanoma of unknown primary origin as a solitary breast lump.","volume":"18","author":"Roy","year":"2008","journal-title":"Melanoma Res"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/excr.1995.1331","article-title":"Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy.","volume":"220","author":"Hubert","year":"1995","journal-title":"Exp Cell Res"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1158\/1078-0432.CCR-06-0758","article-title":"Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.","volume":"12","author":"Prieto","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1073\/pnas.90.8.3466","article-title":"Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.","volume":"90","author":"Lotz","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-11-20210202","first-page":"4635","article-title":"Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.","volume":"6","author":"Honjo","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R27-11-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.prp.2008.09.001","article-title":"Immunohistochemical galectin-3 expression in non-melanoma skin cancers.","volume":"205","author":"Kapucuoglu","year":"2009","journal-title":"Pathol Res Pract"},{"key":"R28-11-20210202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00403-004-0536-6","article-title":"Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.","volume":"296","author":"Vereecken","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/147323000603400116","article-title":"Serum galectin-3 in advanced melanoma patients: a hypothesis on a possible role in melanoma progression and inflammation.","volume":"34","author":"Vereecken","year":"2006","journal-title":"J Int Med Res"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1097\/01.ASN.0000077402.95720.B4","article-title":"Role of galectin-3 in diabetic nephropathy.","volume":"14","author":"Iacobini","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000372-201012000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:43Z","timestamp":1786041343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-201012000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181e02f29","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6818958.6989057","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}